Pirker W - Search Results

1

The role of SCARB2 as susceptibility factor in Parkinson's disease.

Hopfner F, Schulte EC, Mollenhauer B, Bereznai B, Knauf F, Lichtner P, Zimprich A, Haubenberger D, Pirker W, Brücke T, Peters A, Gieger C, Kuhlenbäumer G, Trenkwalder C, Winkelmann J. Hopfner F, et al. Among authors: pirker w. Mov Disord. 2013 Apr;28(4):538-40. doi: 10.1002/mds.25349. Epub 2013 Feb 13. Mov Disord. 2013. PMID: 23408458

2

Pharmacological Treatment of Tremor in Parkinson's Disease Revisited.

Pirker W, Katzenschlager R, Hallett M, Poewe W. Pirker W, et al. J Parkinsons Dis. 2023;13(2):127-144. doi: 10.3233/JPD-225060. J Parkinsons Dis. 2023. PMID: 36847017 Free PMC article. Review.

3

Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease.

Asenbaum S, Brücke T, Pirker W, Podreka I, Angelberger P, Wenger S, Wöber C, Müller C, Deecke L. Asenbaum S, et al. Among authors: pirker w. J Nucl Med. 1997 Jan;38(1):1-6. J Nucl Med. 1997. PMID: 8998140 Free article.

4

[123I]beta-CIT single-photon emission tomography in DOPA-responsive dystonia.

Naumann M, Pirker W, Reiners K, Lange K, Becker G, Brücke T. Naumann M, et al. Among authors: pirker w. Mov Disord. 1997 May;12(3):448-51. doi: 10.1002/mds.870120330. Mov Disord. 1997. PMID: 9159746

5

Imaging the pre- and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: a SPECT study using [123I] epidepride and [123I] beta-CIT.

Naumann M, Pirker W, Reiners K, Lange KW, Becker G, Brücke T. Naumann M, et al. Among authors: pirker w. Mov Disord. 1998 Mar;13(2):319-23. doi: 10.1002/mds.870130219. Mov Disord. 1998. PMID: 9539347

6

Severe akinetic syndrome resulting from a bilateral basal ganglia lesion following bone marrow transplantation.

Pirker W, Baumgartner C, Brugger S, Prayer D, Kandlhofer S, Asenbaum S, Deecke L, Brücke T, Lange KW. Pirker W, et al. Mov Disord. 1999 May;14(3):525-8. doi: 10.1002/1531-8257(199905)14:3<525::aid-mds1028>3.0.co;2-k. Mov Disord. 1999. PMID: 10348486 No abstract available.

7

[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.

Pirker W, Asenbaum S, Bencsits G, Prayer D, Gerschlager W, Deecke L, Brücke T. Pirker W, et al. Mov Disord. 2000 Nov;15(6):1158-67. doi: 10.1002/1531-8257(200011)15:6<1158::aid-mds1015>3.0.co;2-0. Mov Disord. 2000. PMID: 11104200

8

Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study.

Pirker W, Djamshidian S, Asenbaum S, Gerschlager W, Tribl G, Hoffmann M, Brücke T. Pirker W, et al. Mov Disord. 2002 Jan;17(1):45-53. doi: 10.1002/mds.1265. Mov Disord. 2002. PMID: 11835438

9

[123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease.

Gerschlager W, Bencsits G, Pirker W, Bloem BR, Asenbaum S, Prayer D, Zijlmans JC, Hoffmann M, Brücke T. Gerschlager W, et al. Among authors: pirker w. Mov Disord. 2002 May;17(3):518-23. doi: 10.1002/mds.10092. Mov Disord. 2002. PMID: 12112200

10

Measuring the rate of progression of Parkinson's disease over a 5-year period with beta-CIT SPECT.

Pirker W, Holler I, Gerschlager W, Asenbaum S, Zettinig G, Brücke T. Pirker W, et al. Mov Disord. 2003 Nov;18(11):1266-72. doi: 10.1002/mds.10531. Mov Disord. 2003. PMID: 14639666

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters